These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20868268)

  • 1. 1,3-Butadiene: III. Assessing carcinogenic modes of action.
    Kirman CR; Albertini RA; Gargas ML
    Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():74-92. PubMed ID: 20868268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.
    Kirman CR; Albertini RJ; Sweeney LM; Gargas ML
    Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():1-11. PubMed ID: 20868266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
    Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
    Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.
    Hughes K; Meek ME; Walker M; Beauchamp R
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):55-83. PubMed ID: 12587254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
    Bond JA; Medinsky MA
    Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
    Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
    Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes.
    Nieusma JL; Claffey DJ; Maniglier-Poulet C; Imiolczyk T; Ross D; Ruth JA
    Chem Res Toxicol; 1997 Apr; 10(4):450-6. PubMed ID: 9114983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
    Bond JA; Recio L; Andjelkovich D
    Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
    Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
    Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated study of mortality among North American synthetic rubber industry workers.
    Delzell E; Sathiakumar N; Graff J; Macaluso M; Maldonado G; Matthews R;
    Res Rep Health Eff Inst; 2006 Aug; (132):1-63; discussion 65-74. PubMed ID: 17326338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers.
    Ma H; Wood TG; Ammenheuser MM; Rosenblatt JI; Ward JB
    Environ Mol Mutagen; 2000; 36(1):59-71. PubMed ID: 10918361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.